IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $990,132 | +46.7% | 33,394 | -21.5% | 0.03% | +26.9% |
| Q3 2023 | $674,744 | -12.2% | 42,517 | +4.4% | 0.03% | -7.1% |
| Q2 2023 | $768,367 | +411.7% | 40,719 | +4.1% | 0.03% | +366.7% |
| Q1 2023 | $150,163 | +77303.6% | 39,105 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $194 | -99.9% | 39,105 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $187,000 | +1.1% | 39,105 | -5.0% | 0.01% | 0.0% |
| Q2 2022 | $185,000 | -5.6% | 41,177 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $196,000 | -35.9% | 41,177 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $306,000 | +43.7% | 41,177 | +9.6% | 0.01% | +25.0% |
| Q3 2021 | $213,000 | -14.1% | 37,560 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $248,000 | -14.5% | 37,560 | +4.9% | 0.01% | -18.2% |
| Q1 2021 | $290,000 | +8.6% | 35,811 | -13.4% | 0.01% | 0.0% |
| Q4 2020 | $267,000 | +122.5% | 41,364 | +23.8% | 0.01% | +83.3% |
| Q3 2020 | $120,000 | -22.1% | 33,412 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $154,000 | – | 33,412 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |